1.
Biometrics
; 68(1): 239-41; discussion 245-7, 2012 Mar.
Artículo
en Inglés
| MEDLINE
| ID: mdl-21696380
2.
Inflammopharmacology
; 19(5): 243-4, 2011 Oct.
Artículo
en Inglés
| MEDLINE
| ID: mdl-21877123
RESUMEN
In their systematic review, Zhang et al. evaluate randomized controlled trials on the efficacy of Botulinum toxin type A (BoNTA) in helping patients with musculoskeletal disorders. Scoring each trial according to the Jadad scale they note that the studies range from 1 to 5 with an average of 4.1, which they interpret as a testimony of the high quality of the studies included. Unfortunately, we cannot share the author's enthusiasm, as a perfect Jadad score of 5 is no guarantee that a study is of good quality.
Asunto(s)
Toxinas Botulínicas Tipo A/uso terapéutico , Enfermedades Musculoesqueléticas/tratamiento farmacológico , Sistema Musculoesquelético/efectos de los fármacos , Dolor/tratamiento farmacológico , Humanos
3.
Eval Health Prof
; 34(1): 124-6; discussion 127-30, 2011 Mar.
Artículo
en Inglés
| MEDLINE
| ID: mdl-21177639